Michael Scolaro

Michael Scolaro

Oct 20, 2017

Group 6 Copy 11
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can Data Management Tools Improve Research Efficiency and Reproducibility?

    Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve accordingly...

    Are endangered tigers in Nepal threatened by diseases from dogs and cats?

    Through our wildlife health work in Nepal, we have seen sick tigers that show symptoms similar to canine distemper...

    Are American Women of Childbearing Age Changing Their Behaviors in Response to the Zika Virus Outbreak?

    The Zika virus outbreak is an international public health emergency, and is linked to microcephaly and Guillain...

    Backer Badge Funded